Fig. 4From: Evaluation of new and old biomarkers in dogs with degenerative mitral valve diseasecTnI concentrations in ng/mL for each dog in the respective groups at a) baseline and b) follow-up examination, median marked as a bar. c) Significant increase in cTnI concentrations from baseline (1) to follow-up (2) occurred in stage B1 patients. ROC curves and AUC comparing cTnI between dogs with stage C and d) controls, e) stage B1, and f) stage B2. * p < 0.05, ** p < 0.001Back to article page